EPZ020411
CAS No. 1700663-41-7
EPZ020411 ( EPZ-020411 )
Catalog No. M12596 CAS No. 1700663-41-7
EPZ020411 is a potent, selective PRMT6 inhibitor with IC50 of 10 nM.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
Size | Price / USD | Stock | Quantity |
5MG | 212 | In Stock |
|
10MG | 353 | In Stock |
|
100MG | Get Quote | In Stock |
|
200MG | Get Quote | In Stock |
|
500MG | Get Quote | In Stock |
|
1G | Get Quote | In Stock |
|
Biological Information
-
Product NameEPZ020411
-
NoteResearch use only, not for human use.
-
Brief DescriptionEPZ020411 is a potent, selective PRMT6 inhibitor with IC50 of 10 nM.
-
DescriptionEPZ020411 is a potent, selective PRMT6 inhibitor with IC50 of 10 nM, displays 10-fold and 20-fold selectivity over PRMT1/8, and >100-fold over other histone methyltransferases (PRMT3/4/5/7); dose-dependently decreases H3R2 methylation A375 cell line with IC50 of 0.637 uM, with no affect levels of PRMT6 expression; exhibits good bioavailability following subcutaneous dosing in rats making it a suitable tool for potential in vivo target validation studies.
-
SynonymsEPZ-020411
-
PathwayChromatin/Epigenetic
-
TargetHMTase
-
RecptorPRMT6
-
Research AreaOther Indications
-
Indication——
Chemical Information
-
CAS Number1700663-41-7
-
Formula Weight442.59
-
Molecular FormulaC25H38N4O3
-
Purity>98% (HPLC)
-
Solubility10 mM in DMSO
-
SMILESCNCCN(C)CC1=C(NN=C1)C2=CC=C(C=C2)OC3CC(C3)OCCC4CCOCC4
-
Chemical Name1,2-Ethanediamine, N1,N2-dimethyl-N1-[[3-[4-[[trans-3-[2-(tetrahydro-2H-pyran-4-yl)ethoxy]cyclobutyl]oxy]phenyl]-1H-pyrazol-4-yl]methyl]-
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. Mitchell LH, et al. ACS Med Chem Lett. 2015 Apr 6;6(6):655-9.
molnova catalog
related products
-
MS-049
A potent, selective, and cell-active dual inhibitor of PRMT4 and PRMT6 with IC50 of 34±10 nM and 43±7 nM, respectively.
-
CM-272
CM-272 (CM272)is a novel potent, selective and reversible dual inhibitor of G9a/DNMTs with IC50 of 8 nM and 382 nM for G9a and DNMT1, respectively.
-
PFI-2 hydrochloride
A first-in-class, potent and selective inhibitor of SETD7 methyltransferase with Ki app/IC50 of 0.33/2 nM.